Elering AS financials
Elering AS
894500CHL8J099IKJ580 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €387.0M | €201.5M |
| Other income | €11.1M | €6.7M |
| Employee benefits expense | €13.3M | €11.2M |
| Depreciation & amortisation | €47.7M | €45.5M |
| Operating profit (EBIT) | €19.9M | €9.0M |
| Finance costs | €2.6M | €2.3M |
| Profit before tax | €17.4M | €6.7M |
| Income tax expense | €0 | €1.6M |
| Profit for the year | €17.4M | €5.1M |
| Total comprehensive income | €17.4M | €5.1M |
| Cash flow statement | ||
| Net cash from operating activities | €75.1M | €51.1M |
| Net cash from investing activities | €102.2M | -€18.4M |
| Net cash from financing activities | -€10.6M | -€20.6M |
| Dividends paid | €0 | €10.0M |
| Repayments of borrowings | €10.6M | €10.6M |
| Lease liability payments | €71.0K | €54.0K |
| Balance sheet | ||
| Total assets | €1.46B | €1.18B |
| Non-current assets | €1.09B | €1.01B |
| Property, plant & equipment | €1.07B | €1.00B |
| Current assets | €375.0M | €168.0M |
| Inventories | €22.4M | €3.7M |
| Trade & other receivables | €73.3M | €59.7M |
| Cash & equivalents | €229.3M | €62.7M |
| Total equity | €399.5M | €382.1M |
| Non-current liabilities | €753.3M | €731.6M |
| Long-term borrowings | €76.8M | €312.1M |
| Current liabilities | €308.2M | €69.1M |
| Short-term borrowings | €237.3M | €12.0M |
| Trade & other payables | €70.9M | €57.1M |
| Derived metrics | ||
| Operating margin | 5.1% | 4.5% |
| Net margin | 4.5% | 2.5% |
| Return on equity | 4.4% | 1.3% |
| Cash conversion ratio | 4.31× | 10.00× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€18.7M | -€123.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€15.4M | -€20.5M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €47.7M | €45.5M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €24.0K | €257.0K |
| Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities | €34.9M | €224.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | €14.8M | €24.3M |
| Adjustments For Interest Expense | €2.6M | €2.3M |
| Adjustments For Interest Income | €189.0K | €6.0K |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €8.0K | €0 |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits and Investments | -€8.0M | -€42.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €61.5M | €49.2M |
| Equity and Liabilities | €1.46B | €1.18B |
| Finance Income | €197.0K | €16.0K |
| Increase Decrease In Cash and Cash Equivalents | €166.6M | €12.0M |
| Increase Decrease In Working Capital | -€15.5M | -€3.9M |
| Increase Decrease Through Transactions With Owners | €0 | -€10.0M |
| Increase Decrease Through Transfer To Statutory Reserve | €0 | €0 |
| Intangible Assets Other Than Goodwill | €16.9M | €14.6M |
| Interest Paid Classified As Operating Activities | €2.1M | €2.0M |
| Interest Received Classified As Operating Activities | €166.0K | €6.0K |
| Investments In Associates Accounted For Using Equity Method | €53.0K | €0 |
| Issued Capital | €229.9M | €229.9M |
| Liabilities | €1.06B | €800.8M |
| Noncurrent Contract Liabilities | €72.4M | €36.2M |
| Noncurrent Deferred Income Other Than Noncurrent Contract Liabilities | €602.9M | €383.4M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €0 | €912.0K |
| Other Comprehensive Income | €0 | €12.0K |
| Other Expense By Nature | €7.6M | €7.1M |
| Other Noncurrent Liabilities | €1.3M | €0 |
| Proceeds From Government Grants Classified As Investing Activities | €60.8M | €31.8M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €114.0K | €773.0K |
| Purchase of Interests In Associates | €45.0K | €0 |
| Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net of Tax | €0 | -€12.0K |
| Retained Earnings | €151.8M | €134.6M |
| Shortterm Deposits Not Classified As Cash Equivalents | €50.0M | €42.0M |
| Statutory Reserve | €17.9M | €17.6M |
Every line item above is a fact tagged in Elering AS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.